Jun. 29, 2018—Analysis of data from a clinical trial conducted at Vanderbilt suggests that deep brain stimulation (DBS) administered to patients with very early-stage Parkinson’s disease slowed the progression of rest tremor. The study, published June 29 in Neurology, is significant because it is the first evidence of a treatment that may possibly delay the progression of...
Nov. 16, 2017—Researchers believe they can address problems stemming from heart rate, respiration and digestion by untangling which nerves control which bodily functions and then stimulating them with light.
Nov. 8, 2017—Research by a team of Vanderbilt University Medical Center (VUMC) scientists suggests that older people whose hearts pump less blood have blood flow reductions in the temporal lobe regions of the brain, where Alzheimer’s pathology first begins.
Nov. 10, 2016—Vanderbilt researchers have established a new measure of resilience to cognitive impairment in people with asymptomatic Alzheimer’s disease.
Oct. 27, 2016—Costantino Iadecola, M.D., an expert in the molecular pathology of ischemic brain injury and neurodegeneration at Weill Cornell Medical College in New York, will present the 10th annual Meredith S. and John A. Oates Lectureship in Clinical Pharmacology on Nov. 3.
May. 18, 2016—“Neuro-diverse: A Symposium on Autism, Neuroscience and Perceptual Thinking” and an associated evening lecture – both free and open to the public – will take place on the Vanderbilt campus Monday, May 23.
Oct. 15, 2015—Vanderbilt University Medical Center has launched specialized Physical Therapy (PT) residency programs in Orthopaedics (Sports) and Pediatrics in addition to an existing Neurological program, making Vanderbilt one of a handful of hospital systems in the country to offer three or more physical therapy residencies.
Sep. 9, 2015—The extraordinary achievements of nine Vanderbilt endowed chair holders were lauded at a Sept. 8 celebration during which generous donors were thanked.
Aug. 13, 2015—Researchers at Vanderbilt University for the first time have demonstrated in a mouse model that aggregation, the “clumping together” of abnormal proteins, can contribute to a severe form of genetic epilepsy.